(redirected from cytomegalovirus disease)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to cytomegalovirus disease: CMV


n. Abbr. CMV
Any of a group of herpesviruses that attack and enlarge epithelial cells. Such viruses also cause a disease of infants characterized by circulatory dysfunction and microcephaly.


(Microbiology) a virus of the herpes virus family that may cause serious disease in patients whose immune systems are compromised. Abbreviation: CMV


(ˌsaɪ toʊˌmɛg ə loʊˈvaɪ rəs)

n., pl. -rus•es.
a herpesvirus that produces abnormal enlargement of epithelial cells, usu. mildly infectious but a cause of pneumonia in immunodeficient persons and severe systemic damage in the newborn.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cytomegalovirus - any of a group of herpes viruses that enlarge epithelial cells and can cause birth defects; can affect humans with impaired immunological systems
herpes virus, herpes - any of the animal viruses that cause painful blisters on the skin


n. citomegalovirus, grupo de virus pertenecientes a la familia Herpesviridae que infectan humanos y otros animales, y son causantes de la enfermedad de inclusión citomegálica.

cytomegalovirus (CMV)

n citomegalovirus m (CMV)
References in periodicals archive ?
Washing our hands of the congenital cytomegalovirus disease epidemic.
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.
Cytomegalovirus disease during severe drug eruptions: Report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome.
Foscavir is indicated to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) or Cytomegalovirus viremia and cytomegalovirus disease in hematopoietic stem cell transplant (HSCT) patients.
McDevitt, "Etiology and impact of cytomegalovirus disease on solid organ transplant recipients," American Journal of Health-System Pharmacy, vol.
Immunocompromised hosts: Perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Digestive cytomegalovirus disease in AIDS patients.
Citation: "CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation"; Francisco M.
Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation.
UMass Medical School has had recent success bringing other ideas to market, most notably cytogam, a drug licensed to CSL Behring that blocks cytomegalovirus disease associated with organ transplantation; Clarinex, that ubiquitous allergy medicine; and through the medical device company Reflectance Medical Inc.

Full browser ?